Alopecia: Review of Epidemiology, Pathogenesis, and Novel Treatment Strategies
December 2019
in “
Global pharmaceutical sciences review
”
TLDR New treatments for alopecia are being explored due to the limitations of current options.
The review discussed alopecia as an autoimmune disorder affecting approximately 4.5 million people in the United States, where T-lymphocytes attack hair follicles, causing inflammation and hair loss. Traditional treatments like finasteride and minoxidil have been limited due to severe side effects. The article provided a comprehensive overview of the epidemiology, risk factors, pathophysiology, symptoms, and diagnostic criteria of alopecia, with a particular focus on exploring novel treatment strategies.
